Ultima

Armstrong World Industries Introduces New Product to Reduce Carbon in Commercial Buildings

Retrieved on: 
Mercoledì, Maggio 22, 2024
Building Systems, Environment, Architecture, Construction & Property, Sustainability, Carbon, Armstrong World Industries, USDA, Heat, Built environment, Ultima, EC3, LEC, AWI, CO2

With a rich history of product innovation dating to the 1890s and an ongoing focus on sustainable solutions, Armstrong is developing a comprehensive product portfolio for carbon reduction in the built environment.

Key Points: 
  • With a rich history of product innovation dating to the 1890s and an ongoing focus on sustainable solutions, Armstrong is developing a comprehensive product portfolio for carbon reduction in the built environment.
  • These products are designed to lower the carbon emissions over the lifecycle of a building by reducing operational and embodied carbon.
  • Using new technology that includes sustainable, wood-based biochar, Ultima LEC delivers a 43% reduction in the embodied carbon of a ceiling.
  • From design conception to end-of-life product management, Armstrong is giving our customers additional tools to tackle energy efficiency, material waste, construction efficiency and embodied carbon.

Hartwig and Ultima Genomics Collaborate to Reduce Costs for Whole Genome Cancer Profiling, Minimal Residual Disease Testing and Generating Genetic Data at Scale

Retrieved on: 
Lunedì, Aprile 8, 2024
Biotechnology, Medical Devices, Health, Genetics, Oncology, Database, Genetic testing, Disease, Patient, NGS, Research, Cancer, Ultima, Architecture, MRD, Medical foundation, Hartwig, Blood, SNV, Medical imaging

This collaboration aims to reduce test costs and make complete genome-based cancer diagnostics accessible for more patients to have better informed cancer treatment.

Key Points: 
  • This collaboration aims to reduce test costs and make complete genome-based cancer diagnostics accessible for more patients to have better informed cancer treatment.
  • In parallel, platform strengths will be explored for minimal residual disease detection in blood of cancer patients with a one-size-fits-all solution that builds on pre-existing complete tumor profile information.
  • “Collaborating with Hartwig to deploy our technology toward whole genome cancer profiling, MRD testing and generating genomic information at scale is an exciting milestone,” said Gilad Almogy, CEO of Ultima Genomics.
  • Furthermore, lower costs can enable Hartwig to affordably create genetic datasets at national population scale to improve cancer research and ultimately outcomes for future patients.

Ultima Announces UG 100™ and Reveals Disruptive Cost and Accuracy Profile to Enable the Era of the $100 Genome and Beyond

Retrieved on: 
Martedì, Febbraio 6, 2024
Health, Genetics, Clinical Trials, General Health, Pharmaceutical, Biotechnology, Genomics, Robotics, Ultima, Machine learning, GIAB, TB, Automation, Q60, Biology, Algorithm, Genome, SNV

The UG 100TM system also leverages recent advancements in machine learning to improve base calling and variant calling algorithms for improved accuracy and performance.

Key Points: 
  • The UG 100TM system also leverages recent advancements in machine learning to improve base calling and variant calling algorithms for improved accuracy and performance.
  • This scalable configuration enables the $100 genome at an industry-leading price of $1.00 per Gb or $0.30 per million reads.
  • Today, the Company is also introducing ppmSeqTM, a disruptive new mode for extreme raw read accuracy in calling single nucleotide variants (SNVs).
  • With the launch of the UG 100TM system, Ultima looks to enable the next wave of biology powered by low-cost sequencing data generation.

Ultima Genomics to Launch UG 100™ System and Present Data at AGBT

Retrieved on: 
Lunedì, Febbraio 5, 2024
Biotechnology, Health, Genetics, Health Technology, Oncology, Flex, Genomics, Next wave, DNA, Ultima, Broad, Mass meeting, Harvard University, Regeneron Pharmaceuticals, Weill Cornell Medicine, Methylation, Lunch, Genome informatics, MIT, Physiology, Cancer, Genome, Antibiotics

Ultima Genomics, Inc. , a developer of a revolutionary new ultra-high throughput sequencing architecture, will present product and commercial launch details for the UG 100™ system as the Gold Sponsor at the Advances in Genome Biology and Technology (AGBT) General Meeting Feb. 5-8, 2024, in Orlando, FL.

Key Points: 
  • Ultima Genomics, Inc. , a developer of a revolutionary new ultra-high throughput sequencing architecture, will present product and commercial launch details for the UG 100™ system as the Gold Sponsor at the Advances in Genome Biology and Technology (AGBT) General Meeting Feb. 5-8, 2024, in Orlando, FL.
  • The Gold Sponsor workshop will also include presentations by customers and collaborators from multiple leading institutions including:
    Stacey Gabriel, Ph.D., Executive Vice President of Platforms and Scientific Execution, Institute Scientist, Broad Institute of MIT and Harvard
    Aziz Al’Khafaji, Ph.D., Associate Director, Technology Development – Genomics Platform, Broad Institute of MIT and Harvard
    Will Salerno, Ph.D., Executive Director of Genome Informatics & Data Engineering, Regeneron Pharmaceuticals
    Dan Landau, M.D., Ph.D., Professor of Physiology and Biophysics, Weill Cornell Medical College
    Join Ultima for a series of talks and poster sessions, including:
    Ultima Genomics will be hosting the Gold Sponsor Workshop and Lunch entitled “Genomics unleashed: the $100 genome and beyond” at 12:00 pm in Grand Sierra Ballroom D&E
    Ultima technology will be featured in three posters during the Tuesday poster session at 1:30 pm in Palms Ballroom I:
    101 - Advancing cancer genomics with cost-effective whole genome sequencing: somatic variant calling using the UG 100 platform,​ by Hila Benjamin of Ultima Genomics
    518 - A continued evaluation of the Ultima Genomics UG100 platform: operational advancements and new methods for ancient DNA, single-cell, and methylation applications, by Matthew Coole of the Broad Institute
    592 - Integration of mostly-natural sequencing by synthesis with multiple single cell and spatial assays: 10X Flex, Visium and immune profiling,​ by Gila Yanai of Ultima Genomics
    Ultima Genomics will be hosting a Technical Breakfast Workshop entitled “Introducing a New Era: Part Per Million Detection Accuracy with ppmSeq™️ Technology” at 8:00 am in Ultima Suite, Grand Sierra Ballroom C
    Ultima technology will be featured in three posters during the Wednesday poster session at 4:45 pm in Palms Ballroom I:
    557 - Assessment of Ultima Genomics $100 genome for whole genome sequencing-based cancer diagnostics, by Edwin Cuppen of the Hartwig Medical Foundation
    625 - Scalable Dual Indexed Single Cell WGS on Ultima Genomics, ​ by Andrew Wicks of the New York Genome Center​
    Ultima Genomics will be hosting a Technical Breakfast Workshop entitled “Introducing the Next Wave of Single Cell and Omics at Scale” at 8:00 am in Ultima Suite, Grand Sierra Ballroom C

Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing

Retrieved on: 
Martedì, Gennaio 9, 2024
Oncology, Medical Supplies, Health, Health Technology, Genetics, Pharmaceutical, Biotechnology, Senior, Pathology, NGS, SNV, MRD, Patient, Architecture, Collection, DNA, Multimedia, Whole genome sequencing, Cancer, DGX, Lung cancer, Economics, Quest, Genomics, Skin, Hay, Quest Diagnostics, Genome, Ultima, Organization, Machine learning, Breast, Physician, Medical imaging

Ultima recently unveiled its platform technology, a new sequencing architecture that supports sequencing an entire genome for $100.

Key Points: 
  • Ultima recently unveiled its platform technology, a new sequencing architecture that supports sequencing an entire genome for $100.
  • The collaboration will leverage Quest's expertise and scale in oncology, genomics and pathology and national scale in tumor biopsy and blood specimen collection.
  • “Ultima’s technology was designed for applications requiring greater sequencing depth, breadth, or frequency and both MRD testing and whole genome sequencing are premier examples of these.
  • As a result, whole genome sequencing is typically used for rare disease and some oncology testing, but less available for applications targeting large populations.

Ultima Genomics to Present at ASHG and Provide Updated Reference Data Set

Retrieved on: 
Martedì, Ottobre 31, 2023
Health, Genetics, Health Technology, Research, Science, Biotechnology, ASHG, Whole genome sequencing, Genomics, Stanford University, Booth, Genetic disorder, Alternative splicing, Centre for Industry Education Collaboration, UG, Society, Baylor College of Medicine, Fusion, ATAC, American Society of Human Genetics, Human genetics, Baylor, Scale, Ultima, Chemistry, Gene expression, Baylor University, Antibiotics, Music, Fine chemical, Communications satellite

Watchmaker Genomics will demonstrate gene fusion detection via cost-effective whole transcriptome sequencing using the optimized Watchmaker RNA Library prep kit.

Key Points: 
  • Watchmaker Genomics will demonstrate gene fusion detection via cost-effective whole transcriptome sequencing using the optimized Watchmaker RNA Library prep kit.
  • In conjunction with the conference, Ultima will be releasing a new data set demonstrating significant improvements to the technology made through early access.
  • In particular, the data demonstrates significant improvements in indel accuracy made through a variety of advancements across chemistry and bioinformatics.
  • Industry Education Session: Empowering Genomics at Scale Thursday, Nov. 2 | Room 140AB | Talks 3:30 - 4:30 p.m.

Integrated DNA Technologies Reveals Launch of xGen™ Products for Ultima Genomics®

Retrieved on: 
Mercoledì, Settembre 27, 2023
Research, General Health, Pharmaceutical, Oncology, Technology, Infectious Diseases, Genetics, Health Technology, Science, Biotechnology, Other Technology, Health, Other Science, Learning, DNA, XGen Studios, Genomics, NGS, Integrated DNA Technologies, Ligation, Multimedia, RNA, Manager, Chemistry, IDT, Ultima, WGS, Small Business Saturday, Integration, PCR, Fine chemical, Antibiotics, Birth control, Paint

With a mission to accelerate the pace of genomics, Integrated DNA Technologies (IDT), a leading provider of differentiated next generation sequencing (NGS) solutions, announces the availability of xGen NGS products designed exclusively for the Ultima Genomics UG 100™ platform.

Key Points: 
  • With a mission to accelerate the pace of genomics, Integrated DNA Technologies (IDT), a leading provider of differentiated next generation sequencing (NGS) solutions, announces the availability of xGen NGS products designed exclusively for the Ultima Genomics UG 100™ platform.
  • The products are designed to minimize sequence errors from PCR or sequencing that might impact demultiplexing.
  • xGen HybCap Adapters for Ultima Genomics—full-length adapters for library construction prior to hybridization capture, using TA-ligation workflows for incorporating sample indexing during the ligation step.
  • xGen HybCap Lib Amp Primers for Ultima Genomics—premixed PCR primers used to increase yield for sequencing libraries post-hybridization capture.

Pipeworks Studios Welcomes Kirstin Whittle as Vice President of Business Development & Strategic Partnerships

Retrieved on: 
Mercoledì, Settembre 6, 2023
Warner, Business development, Pipeworks Studios, SCEE, Sony, Wing commander, PlayStation 2, Sumo Group, Mindscape, Ultima, Sensible Soccer, Content management, AAA, Kirstin, Games as a service, EUGENE, PlayStation, Partnership, Management, Video game, Maxis

Lindsay Gupton, CEO of Pipeworks Studios, is enthusiastic about Kirstin joining the leadership team and anticipates the opportunity to elevate the company to new heights.

Key Points: 
  • Lindsay Gupton, CEO of Pipeworks Studios, is enthusiastic about Kirstin joining the leadership team and anticipates the opportunity to elevate the company to new heights.
  • EUGENE, Ore., Sept. 6, 2023 /PRNewswire/ -- Pipeworks Studios is proud to announce that Kirstin Whittle will be joining its leadership team as Vice President of Business Development & Strategic Partnerships.
  • Kirstin is an industry veteran with over three decades of experience in building strategic alliances and collaborating with content owners and platform holders to support AAA partnerships for their players.
  • Commenting on her appointment, Lindsay Gupton, CEO said, "I am thrilled and honoured to have Kirstin joining the Pipeworks leadership team.

Ultima Genomics Adds Tenured Strategic and Technology Leadership In Preparation for Commercial Launch

Retrieved on: 
Lunedì, Giugno 26, 2023
BS, University, National Security and Defense Council of Ukraine, Defense, Engineering, Marketing, Integration, Genomics, Head, NGS, Integrated DNA Technologies, DNA sequencing, Electrical engineering, Electronics, Jarosz, MIT, Doctor of Philosophy, MS, Security, Organization, IDT, Physical chemistry, University of Washington Department of Bioengineering, Foundation Medicine, Architecture of Integrated Information Systems, Helicos Biosciences, Product strategy, Management, Tel Aviv University, Architecture, Ultima, Chemistry

Shlomey Derhi will join the Company's R&D and engineering leadership as Head of Architecture and Integration and will be focused on accelerating technology development of the Company's unique sequencing architecture.

Key Points: 
  • Shlomey Derhi will join the Company's R&D and engineering leadership as Head of Architecture and Integration and will be focused on accelerating technology development of the Company's unique sequencing architecture.
  • "We are excited to have two proven and tenured industry leaders join our leadership team at this important stage of our Company," said Gilad Almogy, CEO and founder of Ultima Genomics.
  • She has deep scientific, technical and commercial expertise and will be instrumental in driving customer success, strategy and commercial focus as we transition from early access to commercial launch.
  • He will be pivotal as we prepare our first product, the UG100™ for commercial launch, and continue to advance our unique sequencing architecture."

Cub Cadet Introduces Cutting-Edge Lawn Care Footwear to Showcase Its Engineering and Design Prowess

Retrieved on: 
Mercoledì, Giugno 14, 2023
Online Retail, Fashion, Retail, Footwear, Department Stores, Stanley Black & Decker, NYSE, SWK, Shoe, Cub Cadet, Multimedia, Ultima, Engineering, Shoemaking, Ultima IX: Ascension

The Ultimas, inspired from Cub Cadet’s award-winning Ultima Series™ zero-turn riding lawn mower, introduce a mowing shoe that delivers a fresh take on comfort, aesthetics and performance.

Key Points: 
  • The Ultimas, inspired from Cub Cadet’s award-winning Ultima Series™ zero-turn riding lawn mower, introduce a mowing shoe that delivers a fresh take on comfort, aesthetics and performance.
  • View the full release here: https://www.businesswire.com/news/home/20230614414305/en/
    Ultimas by Cub Cadet, inspired by Cub Cadet’s award-winning Ultima Series™ zero-turn riding lawn mower, deliver a fresh take on comfort, aesthetics and performance.
  • (Photo: Business Wire
    “Cub Cadet prides itself with more than 60 years of engineering excellence and constantly seeks new, innovative ways to enhance the lawn mowing experience for our users.
  • And despite playing such an important role in the process, footwear is usually an afterthought,” said Erin Floto, Brand Manager at Cub Cadet.